1,491 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Colonial River Investments LLC

Colonial River Investments LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,491 shares of the biotechnology company’s stock, valued at approximately $596,000.

Several other large investors have also recently made changes to their positions in the business. PFG Investments LLC lifted its stake in shares of Axon Enterprise by 0.6% in the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after acquiring an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC increased its stake in Axon Enterprise by 1.6% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after purchasing an additional 26 shares during the period. Mather Group LLC. lifted its position in Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 27 shares during the last quarter. CWM LLC boosted its stake in shares of Axon Enterprise by 1.3% during the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after purchasing an additional 36 shares during the period. Finally, SPC Financial Inc. grew its holdings in shares of Axon Enterprise by 2.2% in the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock worth $708,000 after purchasing an additional 38 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Jefferies Financial Group began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. JMP Securities increased their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Barclays boosted their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Robert W. Baird increased their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $412.42.

Get Our Latest Stock Analysis on AXON

Insiders Place Their Bets

In other news, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total value of $318,177.00. Following the completion of the sale, the director now directly owns 3,653 shares in the company, valued at $1,291,445.09. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, President Joshua Isner sold 25,811 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the transaction, the president now owns 228,166 shares in the company, valued at $82,103,253.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Julie A. Cullivan sold 900 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now directly owns 3,653 shares in the company, valued at approximately $1,291,445.09. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 369,172 shares of company stock valued at $136,270,842. 6.10% of the stock is owned by insiders.

Axon Enterprise Stock Up 28.7 %

AXON stock opened at $603.18 on Friday. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. Axon Enterprise, Inc. has a 1-year low of $212.88 and a 1-year high of $611.88. The stock has a market capitalization of $45.58 billion, a P/E ratio of 155.86, a P/E/G ratio of 15.15 and a beta of 0.94. The business has a fifty day moving average price of $414.16 and a 200-day moving average price of $347.27.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.